BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28375557)

  • 1. Genomewide association study on monoclonal gammopathy of unknown significance (MGUS).
    Thomsen H; Campo C; Weinhold N; da Silva Filho MI; Pour L; Gregora E; Vodicka P; Vodickova L; Hoffmann P; Nöthen MM; Jöckel KH; Langer C; Hajek R; Goldschmidt H; Hemminki K; Försti A
    Eur J Haematol; 2017 Jul; 99(1):70-79. PubMed ID: 28375557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomewide profiling of copy-number alteration in monoclonal gammopathy of undetermined significance.
    Mikulasova A; Smetana J; Wayhelova M; Janyskova H; Sandecka V; Kufova Z; Almasi M; Jarkovsky J; Gregora E; Kessler P; Wrobel M; Walker BA; Wardell CP; Morgan GJ; Hajek R; Kuglik P
    Eur J Haematol; 2016 Dec; 97(6):568-575. PubMed ID: 27157252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enrichment of B cell receptor signaling and epidermal growth factor receptor pathways in monoclonal gammopathy of undetermined significance: a genome-wide genetic interaction study.
    Chattopadhyay S; Thomsen H; da Silva Filho MI; Weinhold N; Hoffmann P; Nöthen MM; Marina A; Jöckel KH; Schmidt B; Pechlivanis S; Langer C; Goldschmidt H; Hemminki K; Försti A
    Mol Med; 2018 Jun; 24(1):30. PubMed ID: 30134812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coinherited genetics of multiple myeloma and its precursor, monoclonal gammopathy of undetermined significance.
    Clay-Gilmour AI; Hildebrandt MAT; Brown EE; Hofmann JN; Spinelli JJ; Giles GG; Cozen W; Bhatti P; Wu X; Waller RG; Belachew AA; Robinson DP; Norman AD; Sinnwell JP; Berndt SI; Rajkumar SV; Kumar SK; Chanock SJ; Machiela MJ; Milne RL; Slager SL; Camp NJ; Ziv E; Vachon CM
    Blood Adv; 2020 Jun; 4(12):2789-2797. PubMed ID: 32569378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inherited genetic susceptibility to monoclonal gammopathy of unknown significance.
    Weinhold N; Johnson DC; Rawstron AC; Försti A; Doughty C; Vijayakrishnan J; Broderick P; Dahir NB; Begum DB; Hosking FJ; Yong K; Walker BA; Hoffmann P; Mühleisen TW; Langer C; Dörner E; Jöckel KH; Eisele L; Nöthen MM; Hose D; Davies FE; Goldschmidt H; Morgan GJ; Hemminki K; Houlston RS
    Blood; 2014 Apr; 123(16):2513-7; quiz 2593. PubMed ID: 24449210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case-control study.
    Grass S; Preuss KD; Ahlgrimm M; Fadle N; Regitz E; Pfoehler C; Murawski N; Pfreundschuh M
    Lancet Oncol; 2009 Oct; 10(10):950-6. PubMed ID: 19767238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A first Czech analysis of 1887 cases with monoclonal gammopathy of undetermined significance.
    Sandecká V; Hájek R; Pour L; Špička I; Ščudla V; Gregora E; Radocha J; Walterová L; Kessler P; Zahradová L; Adamová D; Valentova K; Vonke I; Obernauerová J; Starostka D; Wróbel M; Brožová L; Jarkovský J; Mikulášová A; Říhová L; Ševčíková S; Straub J; Minařík J; Adam Z; Krejčí M; Král Z; Maisnar V;
    Eur J Haematol; 2017 Jul; 99(1):80-90. PubMed ID: 28384387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Untangling fracture risk in monoclonal gammopathy of undetermined significance: A population-based cohort study.
    Rögnvaldsson S; Aspelund T; Thorsteinsdóttir S; Turesson I; Björkholm M; Landgren O; Kristinsson SY
    Eur J Haematol; 2021 Jul; 107(1):137-144. PubMed ID: 33840154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agent Orange Exposure and Monoclonal Gammopathy of Undetermined Significance: An Operation Ranch Hand Veteran Cohort Study.
    Landgren O; Shim YK; Michalek J; Costello R; Burton D; Ketchum N; Calvo KR; Caporaso N; Raveche E; Middleton D; Marti G; Vogt RF
    JAMA Oncol; 2015 Nov; 1(8):1061-8. PubMed ID: 26335650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    van de Donk NW; Mutis T; Poddighe PJ; Lokhorst HM; Zweegman S
    Int J Lab Hematol; 2016 May; 38 Suppl 1():110-22. PubMed ID: 27161311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monoclonal gammopathy of undetermined significance : when and why to look for them ?].
    Meuleman N; Vercruyssen M
    Rev Med Brux; 2018; 39(4):302-306. PubMed ID: 30320992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary monoclonal gammopathy of undetermined significance is frequently associated with high response rate and superior survival in patients with plasma cell dyscrasias.
    Zou D; An G; Zhu G; Wang J; Shi L; Meng H; Xu Y; Sui W; Deng S; Zhan F; Qiu L
    Biol Blood Marrow Transplant; 2014 Mar; 20(3):319-25. PubMed ID: 24296491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
    Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.
    Sigurdardottir EE; Turesson I; Lund SH; Lindqvist EK; Mailankody S; Korde N; Björkholm M; Landgren O; Kristinsson SY
    JAMA Oncol; 2015 May; 1(2):168-74. PubMed ID: 26181017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal Gammopathy of Undetermined Significance After Kidney Transplantation: Single-Center Experience.
    Alfano G; Fontana F; Colaci E; Messerotti A; Bettelli F; Potenza L; Luppi M; Cappelli G
    Transplantation; 2017 Nov; 101(11):e337-e342. PubMed ID: 28731904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monoclonal gammopathy of undetermined significance--potential risk factor of multiple myeloma].
    Stelmach-Gołdyś A; Czarkowska-Paczek B
    Przegl Lek; 2012; 69(5):194-6. PubMed ID: 23050415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of Rice Bran Arabinoxylan to Curcumin Therapy May Be of Benefit to Patients With Early-Stage B-Cell Lymphoid Malignancies (Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Stage 0/1 Chronic Lymphocytic Leukemia): A Preliminary Clinical Study.
    Golombick T; Diamond TH; Manoharan A; Ramakrishna R
    Integr Cancer Ther; 2016 Jun; 15(2):183-9. PubMed ID: 27154182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperdiploidy is a common finding in monoclonal gammopathy of undetermined significance and monosomy 13 is restricted to these hyperdiploid patients.
    Brousseau M; Leleu X; Gerard J; Gastinne T; Godon A; Genevieve F; Dib M; Lai JL; Facon T; Zandecki M;
    Clin Cancer Res; 2007 Oct; 13(20):6026-31. PubMed ID: 17947464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pitfalls of monoclonal gammopathy].
    Meuleman N
    Rev Med Brux; 2013 Sep; 34(4):335-8. PubMed ID: 24195249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide association study of monoclonal gammopathy of unknown significance (MGUS): comparison with multiple myeloma.
    Thomsen H; Chattopadhyay S; Weinhold N; Vodicka P; Vodickova L; Hoffmann P; Nöthen MM; Jöckel KH; Langer C; Hajek R; Hallmans G; Pettersson-Kymmer U; Ohlsson C; Späth F; Houlston R; Goldschmidt H; Hemminki K; Försti A
    Leukemia; 2019 Jul; 33(7):1817-1821. PubMed ID: 30737484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.